Arrowhead Pharmaceuticals, Inc. (ARWR): Cash & Equivalents
Older than the company's other figures. The latest Cash & Equivalents is for the year ended 2021-09-30, while the company's latest annual report covers the year ended 2025-09-30. Its later filings do not report this line under the concept TickerFacts maps.
$184.43M
As of 2021-09-30
+82.9%
3-year compound annual growth
+16.7%
5-year compound annual growth
+37.7%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2021-09-30 | $184.43M | +28.5% | 2021-11-22, Balance as of period end |
| 2020-09-30 | $143.58M | -35.3% | 2021-11-22, Balance as of period end |
| 2019-09-30 | $221.80M | +636.1% | 2020-11-23, Balance as of period end |
| 2018-09-30 | $30.13M | +21.3% | 2019-11-25, Balance as of period end |
| 2017-09-30 | $24.84M | -70.9% | 2018-12-11, Balance as of period end |
| 2016-09-30 | $85.37M | +5.1% | 2018-12-11, Balance as of period end |
| 2015-09-30 | $81.21M | -38.7% | 2017-12-12, Balance as of period end |
| 2014-09-30 | $132.51M | +593.2% | 2016-12-14, Balance as of period end |
| 2013-09-30 | $19.11M | +466.0% | 2015-12-14, Balance as of period end |
| 2012-09-30 | $3.38M | -55.0% | 2014-11-25, Balance as of period end |
| 2011-09-30 | $7.51M | +9.6% | 2013-12-18, Balance as of period end |
| 2010-09-30 | $6.85M | +238.9% | 2012-12-28, Balance as of period end |
| 2009-09-30 | $2.02M | n/a | 2011-12-20, Balance as of period end |